✉news HealthMedicine first seen 11 h ago, last 5 h ago, peak #5
IBA and Penn Medicine Launch Noventra Oncology Alliance
Original: IBA, Penn Medicine Announce Noventra Oncology Alliance Joint Venture
IBA and Penn Medicine have announced a joint venture called the Noventra Oncology Alliance, combining the particle therapy technology company's expertise with the academic medical center's clinical and research capabilities. The partnership is aimed at advancing cancer treatment, though further details about its scope, funding and first projects have not yet been made widely available.
Why now: The announcement of a new oncology-focused joint venture between a major proton therapy provider and a leading US academic medical center is fresh corporate news of interest to the medical and investment communities.
IBAPenn MedicineNoventra Oncology Alliance
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/201171